Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $272.99 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $219.44 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $27.55 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $26.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.55 | 2 | Janssen Pharmaceuticals, Inc ($27.55) |
| 2023 | $75.39 | 3 | Alkermes, Inc. ($75.39) |
| 2022 | $19.05 | 1 | Alkermes, Inc. ($19.05) |
| 2017 | $125.00 | 1 | Alkermes, Inc. ($125.00) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: Neuroscience | ||||||
| 03/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/26/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: CNS | ||||||
| 05/24/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: CNS | ||||||
| 03/16/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: CNS | ||||||
| 11/16/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: CNS | ||||||
| 12/05/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
About Dr. Rinata Wagle, MD
Dr. Rinata Wagle, MD is a Psychiatry healthcare provider based in Martinez, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649353319.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rinata Wagle, MD has received a total of $272.99 in payments from pharmaceutical and medical device companies, with $53.55 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($272.99).
Practice Information
- Specialty Psychiatry
- Location Martinez, CA
- Active Since 10/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1649353319
Products in Payments
- Aristada 441 mg (Drug) $125.00
- ARISTADA (Drug) $69.31
- INVEGA SUSTENNA (Drug) $27.55
- ABILIFY MAINTENA (Drug) $26.00
- LYBALVI (Drug) $25.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Martinez
Tarun Bhandari, M.d, M.D
Psychiatry — Payments: $13,306
Mark Bloch
Psychiatry — Payments: $3,117
James Wallace, Md, MD
Psychiatry — Payments: $1,601
Zohaib Abbasi
Psychiatry — Payments: $1,552
Brian Holoyda, Md, Mph, Mba, MD, MPH, MBA
Psychiatry — Payments: $980.94
Alina Faramazyan, Md, MD
Psychiatry — Payments: $817.42